Bayer is studying a new potential treatment for liver cancer. 🙏
Researchers have developed a protein, called a monoclonal antibody, which can find and attach itself to another protein present on the surface of liver cancer cells. This can help the new treatment to specifically target cancer cells in the liver.
In this study, researchers want to understand the distribution and processing of this monoclonal antibody in people with liver cancer.
For this early-stage study, there is no therapeutic benefit. However, the research may help scientists develop a new treatment for people with liver cancer and find a dose to be tested in future studies.
All participants will be compensated for their participation.
The risks appear minimal. If you would like to contribute to the future of HCC research and you live in or near Phoenix, Miami, or Los Angeles, you can learn more here: clinicaltrials.gov/study/NC...
đź’™Andrea
P.S. Blue Faery never recommends, endorses, or supports a specific drug or treatment. You have to do what is right for you!